This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignees: Agency for Science, Technology and Research, Singapore Health Services Pte Ltd. Active years: 2025.
Company Filing History:
1 out of 1,556 
1 out of 140 
Years Active: 2025
Title: Innovations of Xiaosai Yao in Renal Cell Carcinoma Research
Introduction
Xiaosai Yao is a notable inventor based in Singapore, recognized for his contributions to the field of medical research, particularly in the area of clear cell renal cell carcinoma (ccRCC). His innovative work has led to the development of a biomarker set that plays a crucial role in the detection and management of this type of cancer.
Latest Patents
Xiaosai Yao holds 1 patent related to clear cell renal cell carcinoma biomarkers. This patent discloses a comprehensive biomarker set for ccRCC, along with a detection system that utilizes these biomarkers. The methods outlined in the patent include determining whether a subject has or shows recurrence of ccRCC, assessing whether a renal mass sample is benign or malignant, and evaluating a subject's response to systemic treatment. Additionally, the patent describes a kit designed for carrying out these methods.
Career Highlights
Throughout his career, Xiaosai Yao has worked with prominent organizations such as the Agency for Science, Technology and Research and Singapore Health Services Pte Ltd. His experience in these institutions has significantly contributed to his expertise in cancer research and biomarker development.
Collaborations
Xiaosai Yao has collaborated with esteemed colleagues, including Patrick Tan and Jing Kai Tan, to advance research in the field of renal cell carcinoma. Their joint efforts have fostered innovation and enhanced the understanding of ccRCC.
Conclusion
Xiaosai Yao's work in developing biomarkers for clear cell renal cell carcinoma represents a significant advancement in cancer detection and treatment. His contributions continue to impact the medical community and improve patient outcomes.